Alvotech Ordinary Shares (ALVO) is a publicly traded Healthcare sector company. As of November 11, 2026, ALVO trades at $4.74 with a market cap of $1.74B and a P/E ratio of 0.00. ALVO moved +0.92% today. Year to date, ALVO is +0.51%; over the trailing twelve months it is -11.74%. Its 52-week range spans $2.94 to $11.85. Analyst consensus is strong buy with an average price target of $7.67. Rallies surfaces ALVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ALVO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.74 |
| Market Cap | $1.74B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.85 |
| 52-Week Low | $2.94 |
| Volume | 727.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover ALVO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.67.